BITOX, a multidisciplinary platform to discuss severe cases of immunotoxicy in cancer patients treated with immunotherapy exists 2 years in march 2023. We are happy that we were already able to discuss 130 patients cases with the help of our BITOX community to which some of you belong already. Neurological toxicity ranging from cerebritis to peripheral mononeuritis was one of the most prevalent toxicities discussed up to now.
Our most important New Year’s resolution is improving the BITOX meetings for everyone involved. We would appreciate it if you could carve out 5 minutes out of your day to fill out this survey. We aim to implement your suggestions for improvement by our second anniversary in March of this year.
If you are interested to follow our agenda or get invites for our meetings, please let us know via this email. As such you will receive an outlook invite for the next 8 meetings that you can accept as a placeholder in your agenda, to be aware of the following meeting dates. The Teamslink to participate together with the agenda of the meeting will, as usual, be distributed on the Friday before the meeting.
We would like to thank you for your input and support and look forward to an interesting and safer immunotherapy future together.
Marthe & Sandrine